Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process
- PMID: 34501257
- PMCID: PMC8432013
- DOI: 10.3390/jcm10173810
Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process
Abstract
International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification-in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.
Keywords: benign gynecologic disease; consensus study; fertility preservation; modified Delphi method; oocyte vitrification.
Conflict of interest statement
The authors declare no conflict of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
[French clinical practice guidelines developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease].Gynecol Obstet Fertil Senol. 2022 Mar;50(3):211-219. doi: 10.1016/j.gofs.2022.01.003. Epub 2022 Jan 19. Gynecol Obstet Fertil Senol. 2022. PMID: 35063688 French.
-
Oocyte vitrification for fertility preservation for both medical and nonmedical reasons.Fertil Steril. 2021 May;115(5):1091-1101. doi: 10.1016/j.fertnstert.2021.02.006. Fertil Steril. 2021. PMID: 33933172 Review.
-
Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.Fertil Steril. 2020 Apr;113(4):836-844. doi: 10.1016/j.fertnstert.2019.11.017. Epub 2020 Mar 4. Fertil Steril. 2020. PMID: 32145929
-
[Endometriosis and fertility preservation: CNGOF-HAS Endometriosis Guidelines].Gynecol Obstet Fertil Senol. 2018 Mar;46(3):368-372. doi: 10.1016/j.gofs.2018.02.010. Epub 2018 Mar 9. Gynecol Obstet Fertil Senol. 2018. PMID: 29530556 Review. French.
-
Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.Hum Reprod. 2017 Sep 1;32(9):1802-1811. doi: 10.1093/humrep/dex218. Hum Reprod. 2017. PMID: 29117320 Free PMC article.
Cited by
-
Feasibility and efficiency of delayed ovarian stimulation and metaphase II oocyte banking for fertility preservation and childbearing desire after fertility-impairing treatment.Sci Rep. 2023 Sep 20;13(1):15661. doi: 10.1038/s41598-023-42583-3. Sci Rep. 2023. PMID: 37730827 Free PMC article.
-
Fertility Preservation in Children and Adolescents during Oncological Treatment-A Review of Healthcare System Factors and Attitudes of Patients and Their Caregivers.Cancers (Basel). 2023 Sep 2;15(17):4393. doi: 10.3390/cancers15174393. Cancers (Basel). 2023. PMID: 37686669 Free PMC article. Review.
-
Oocyte cryopreservation for women with endometriosis: Justification, indications, and reproductive outcomes.Clin Exp Reprod Med. 2024 Dec;51(4):277-284. doi: 10.5653/cerm.2023.06492. Epub 2024 May 7. Clin Exp Reprod Med. 2024. PMID: 38710533 Free PMC article.
-
Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat.J Clin Med. 2022 Aug 4;11(15):4559. doi: 10.3390/jcm11154559. J Clin Med. 2022. PMID: 35956174 Free PMC article. Review.
References
-
- ESHRE Guideline Group on Female Fertility Preservation. Anderson R.A., Amant F., Braat D., D’Angelo A., Lopes S.M.C.d.S., Demeestere I., Dwek S., Frith L., Lambertini M., et al. ESHRE Guideline: Female Fertility Preservation. Hum. Reprod. Open. 2020;2020:hoaa052. doi: 10.1093/hropen/hoaa052. - DOI - PMC - PubMed
-
- Oktay K., Bedoschi G., Berkowitz K., Bronson R., Kashani B., McGovern P., Pal L., Quinn G., Rubin K. Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines. J. Pediatr. Adolesc. Gynecol. 2016;29:409–416. doi: 10.1016/j.jpag.2015.10.011. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources